Advertisement
News
Subscribe to MDT Magazine News

Webmedx Strengthens Quality Program and Improves Patient Safety in Compliance with New Industry Standards for Clinical Documentation

September 2, 2010 11:35 am | by Bio-Medicine.Org | Comments

ATLANTA, Sept. 2 /- Webmedx , the third largest medical transcription service provider in the U.S. and a premier supplier of speech recognition and quality analytics technology, reinforced their commitment to quality and patient safety by announcing important changes to their quality...

TOPICS:

The SCOOTER Store Creates Home Care Equipment Division

September 2, 2010 11:35 am | by Bio-Medicine.Org | Comments

NEW BRAUNFELS, Texas, Sept. 2 /- The SCOOTER Store, the nation's largest provider of power mobility products and services, has announced the creation of a new internal division focusing on Home Care equipment, accessories and related services to complement its traditional power mobility...

TOPICS:

Ascension Orthopedics Receives FDA Approval for TITAN™ Modular Total Shoulder System

September 2, 2010 11:34 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Sept. 2 /- Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces FDA approval to market the TITAN™ Modular Total Shoulder System. This newly designed system redefines modularity by providing multiple surgical solutions for shoulder...

TOPICS:
Advertisement

Mark S. Rangell Appointed Chief Operating Officer for Sandata Technologies, LLC

September 2, 2010 11:33 am | by Bio-Medicine.Org | Comments

PORT WASHINGTON, N.Y., Sept. 2 /- Sandata Technologies, LLC, a leading national provider of information technology solutions to the home healthcare community, today announced the hiring of Mark S. Rangell as its Chief Operating Officer. Mr. Rangell will be in charge of Sandata's...

TOPICS:

CLC bio expands Cambridge office, looks to hire

September 2, 2010 9:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Denmark-based CLC bio, a life sciences services company providing hardware, software and data analytics, is expanding its presence in Cambridge with a new North American headquarters location.

Guidance for Industry and FDA Staff - Impact-Resistant Lenses: Questions and Answers

September 2, 2010 9:32 am | by U.S. Food & Drug Administration | Comments

Eyeglasses and sunglasses (eyewear) that are intended to affect the structure or function of the body or intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, are devices...

Federal Register: Guidance for Industry and Food and Drug Administration Staff; Impact-Resistant Lenses: Questions and Answers; Availability.

September 2, 2010 9:32 am | by U.S. Food & Drug Administration | Comments

The FDA is announcing the availability of the guidance entitled 'Impact-Resistant Lenses: Questions and Answers.' This guidance document answers manufacturer, importer, and consumer questions on impact-resistant lenses, including questions on test...

Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada

September 2, 2010 6:32 am | by Bio-Medicine.Org | Comments

MONTREAL, Sept. 2 /- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP ), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced today the final data set from its Phase 3 study of...

TOPICS:
Advertisement

NewCardio CEO Increases Equity Position

September 2, 2010 6:32 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., Sept. 2 /- NewCardio (OTC Bulletin Board: NWCI ) a cardiac diagnostic technology provider, today announced that Vincent Renz, Jr., NewCardio's President and CEO, purchased 128,000 shares during his trading window in open market transactions in the two weeks following...

TOPICS:

Daxor Announces Third Quarter Dividend and Update on Use of Blood Volume Analyzer in Heart Failure

September 2, 2010 4:45 am | by The Associated Press | Comments

Daxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced that the Board of Directors has voted to declare a dividend of $0.25 per share. The dividend will be paid to shareholders of record as of Wednesday, September 15, 2010. The dividend...

Office of Device Evaluation Annual Performance Report Fiscal Year 2009

September 2, 2010 4:35 am | by U.S. Food & Drug Administration | Comments

In the past, the ODE Annual Report included information from and about the ODE Review Divisions, our initiatives, and data analysis from the ODE Program Operations Staff (POS). The FY 09 Report only includes data from POS on our premarket review program.

TOPICS:

Canadian Pharmacy Intermediary SaveRxCanada.com Enhances Online Shopping System

September 2, 2010 3:32 am | by Bio-Medicine.Org | Comments

MIAMI, Sept. 2 /- SaveRxCanada.com, the premier Canadian pharmacy intermediary since 2004, announced an enhancement to its full online shopping system. SaveRxCanada.com has been at the forefront of connecting consumers to affordable Canada drugs though its unique network of licensed...

TOPICS:

13th Annual Henry Schein Back-to-School Program Serves Record Number of Children

September 2, 2010 3:32 am | by Bio-Medicine.Org | Comments

MELVILLE, N.Y., Sept. 2 /- Henry Schein, Inc. (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, is helping a record number of children return to school wearing new outfits and carrying backpacks filled with school supplies and...

TOPICS:

Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America

September 2, 2010 1:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO and OSAKA, Japan, Sept. 2 /- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) and Takeda Pharmaceutical Company Limited (TSE: 4502), today announced that they have entered into an exclusive partnership to develop and commercialize Contrave® (naltrexone SR/bupropion SR),...

TOPICS:

Groundbreaking RF MEMS start-up DelfMEMS secures $1.9M funding

September 1, 2010 11:33 pm | by I-Micronews | Comments

DelfMEMS, a rising player in the field of Radiofrequency components and developer of innovative MEMS (Micro-Electro-Mechanical-Systems) switching solutions, announces that the company has secured 1.5M? ($1,9M) in venture capital (VC) funds.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading